Results 21 to 30 of about 1,148 (137)

Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania [version 1; peer review: 3 approved] [PDF]

open access: yesWellcome Open Research, 2019
Introduction: Substandard and falsified medicines undermine health systems. We sought to unravel the political and economic factors which drive the production of these products, and to explain how they reach patients.
Elizabeth Pisani   +5 more
doaj   +2 more sources

Countering counterfeits: The role of nurse practitioners in the fight against substandard and falsified medicines. [PDF]

open access: yesJ Am Assoc Nurse Pract
Substandard and falsified (SF) medicines, also referred to as counterfeit drugs, represent a global public health emergency. These products range from drugs with no or little active ingredient to medicines laced with illicit fentanyl. Counterfeits can be copies of brand, generic, or over-the-counter medicines.
Rusatira JC, Ahmed S.
europepmc   +4 more sources

Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001-2011). [PDF]

open access: yesBMJ Open, 2013
ObjectiveTo determine the extent of substandard and falsified medicines in the UK.DesignA retrospective review of drug alerts and company-led recalls.SettingThe Medicines and Healthcare Products Regulatory Agency (MHRA) website search for drug alerts issued between 2001 and 2011.Eligibility criteriaDrug alerts related to quality defect in medicinal ...
Almuzaini T, Sammons H, Choonara I.
europepmc   +5 more sources

The urgent need for African research collaboration on medicine quality [PDF]

open access: yesNature Communications
Substandard and falsified medicines threaten African health systems, yet research on this crisis is fragmented and concentrated in few countries, predominantly led by Global North institutions.
Fanqi Zeng   +4 more
doaj   +2 more sources

Combating substandard and falsified medicines in China: policy barriers and the role of pharmaceutical track-and-trace systems

open access: yesCritical Public Health
Substandard and falsified medicines (SF medicines) pose a severe threat to population health and safety. China has a large proportion of SF medicines, imposing a heavy economic burden and exacerbating inequities in access to quality medications ...
Tangsiwei Xin
exaly   +3 more sources

Knowledge, attitudes and practices on substandard and falsified medicines for human and animal use in Wakiso district, Uganda [PDF]

open access: yesJournal of Pharmaceutical Policy and Practice
Linda Gibson   +2 more
exaly   +2 more sources

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study

open access: yesPLoS ONE, 2023
The prevalence of substandard and falsified medicines in low- and middle-income countries (LMICs) is a major global public health concern. Multiple screening technologies for post-market surveillance of medicine quality have been developed but there ...
Colleen R. Higgins   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy